|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1 placebo-controlled, double-blinded, randomized trial to evaluate the safety and immunogenicity of Ad26-ENVA and Ad35-ENV HIV vaccines in healthy HIV-uninfected adult volunteers
HVTN 091 (IAVI B003/IPCAVD 004) is a Phase I clinical trial to evaluate the safety and immunogenicity of Ad26.ENVA.01 (rAd26) and Ad35-ENV (rAd35).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.